Priligy – safe and effective for premature ejaculation
Published 06/24/2011 | 
Priligy is a drug for PE treatment that is undergoing several clinical studies to be approved by FDA. According to the results of a phase 2 double-blind, randomized, placebo-controlled, 3-phase crossover trial the drug is safe and effective for getting more control over early ejaculation in men.
To estimate the tolerability and efficacy of the drug in comparison to placebo 166 male patients aged 23 to 64 years were tested. They suffer from a baseline intravaginal ejaculatory latency time (IELT) less than1 minute. They received the drug in doses of 30, 60 and 100mg and placebo in a series of three crossover treatment periods. All subjects had monogamous relationships.
Results of the study showed that Priligy is effective. It significantly increased the time of ejaculation compared with placebo.
The 62% tested males reported satisfaction from intercourse “good to very good” compared with (27%) placebo. The most common side effects reported were nausea and headache.
The results of the studies demonstrate that Priligy can be taken when needed and that the drug provides significant improvement in premature ejaculation disorder.
